You have 9 free searches left this month | for more free features.

Siponimod

Showing 26 - 32 of 32

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Polymyositis Trial in Worldwide (Placebo, BAF312)

Terminated
  • Polymyositis
  • Phoenix, Arizona
  • +7 more
Dec 9, 2020

Relapsing Remitting Multiple Sclerosis Trial in Worldwide (BAF312)

Completed
  • Relapsing Remitting Multiple Sclerosis
  • Miami, Florida
  • +45 more
Feb 27, 2018

Polymyositis, Dermatomyositis Trial in Worldwide (BAF312, Placebo)

Terminated
  • Polymyositis
  • Dermatomyositis
  • Boston, Massachusetts
  • +5 more
Apr 3, 2019

ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS)

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Blood withdrawal
  • Pozzilli, Isernia, Italy
    IRCCS Neuromed
Oct 7, 2019

Multiple Sclerosis, Spasticity Trial in Pozzilli (lumbar puncture and blood withdrawal, Intermittent theta burst stimulation

Not yet recruiting
  • Multiple Sclerosis
  • Spasticity
  • lumbar puncture and blood withdrawal
  • Intermittent theta burst stimulation (iTBS) therapeutic protocol for spasticity
  • Pozzilli, Isernia, Italy
    IRCCS Neuromed
Jul 2, 2019

Relapsing-remitting Multiple Sclerosis Trial in Worldwide (BAF312, Placebo)

Completed
  • Relapsing-remitting Multiple Sclerosis
  • Cullman, Alabama
  • +71 more
Dec 26, 2019

Healthy Trial in East Hanover (BAF 312)

Completed
  • Healthy
  • BAF 312
  • East Hanover, New Jersey
    Novartis
Nov 28, 2007